Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 11
21
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Metabolism of 26,27-hexafluoro-1α,25-dihydroxyvitamin D3 and 26,27-hexafluoro1α,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24

, , , , , , , , , , & show all
Pages 1055-1062 | Published online: 22 Sep 2008

References

  • AKIYOSHI-SHIBATA, M., SAKAKI, T., OHYAMA, Y., NOSHIRO, M., OKUDA, K. and YABUSAKI, Y., 1994, Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase: a study with the mature enzyme expressed in Escherichia coli. European Journal of Biochemistry, 224, 335–343.
  • BECKMAN, M. J., TADIKONDA, P., WERNER, E., PRAHL, J., YAMADA, S. and DELucA, H. F., 1996, Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry, 35, 8465–8472.
  • HARADA, M., MIYAHARA, T., MIYATA, M., TOMITA, I., OKAYACHI, H., IKEMOTO, Y., HIGUCHI, S., OTOMO, S., KOZUKA, H. and IKEKAWA, N., 1992, Effect on cultured neonatal mouse calvariae of la, 25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1a,23,25-trihydroxyvitamin D3. Bone and Mineral, 18, 41–49.
  • HARADA, M., MIYAHARA, T., KAJITA-KONDO, S., KOZAKAI, A., HIGUCHI, S., OTOMO, S. and KOZUKA, H., 1994, Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1a,25-dihydroxyvitamin D3 and 1a,25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria. Research Communications in Molecular Pathology and Pharmacology, 86, 183–193.
  • HAYASHI, K., AKIYOSHI-SHIBATA, T., SAKAKI T. and YABUSAKI, Y., 1998, Rat CYP24 catalyses 23S-hydroxylation of 26,26,26,27,27,27-hexalluorocalcitriol in vitro. Xenobiotica, 28, 457–463.
  • HONDA, A., NAKASHIMA, N., SHIDA, Y., MORI, Y., NAGATA, A. and ISHIZUKA, S., 1993, Modification of 1a,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26, 27,27,27-hexafluoro atoms in human promyelocytic leukemia (HL-60) cells: isolation and identification of a novel bio-active metabolite, 26,26,26,27,27,27-hexafluoro-1,23(S)25-trihydroxyvitamin D3. Biochemical Journal, 295, 509–516.
  • INABA, M., °KUNO, S., NISIZAWA, Y., IMANISHI, Y., KATSUMATA, T., SUGATA, I. and MORII, H., 1993, Effect of substituting fluoride for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3. Biochemical Pharmacology, 45, 2331–2336.
  • IsHIBAsm, E., SEKI, H. and KATSUMATA, M., 1996, Effects of Falecakitriol on osteocalcin secretion and its metabolism in human osteosarcoma cell line, MG-63. Clinical Report, 30, 2983–2990.
  • KOMURO, S., KANAMARU, H., NAKATSUKA, I. and YOSHITAKE, A., 1996, Disposition and metabolism of ST-630(2): metabolism after single administration of 3H-ST-630 in rats. Xenobiotk Metabolism and Disposition, 11,518–529.
  • MAKIN, G., LOHNES, D., BYFORD, V., RAY, R. and JoNEs, G., 1989, Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Biochemical Journal, 262, 173–180.
  • MIYAHARA, T., HARADA, M., KOZAKAI, A., MATSUMOTO, M., HASHIMOTO, K., INouE, H., YODA, K., NAKATSU, T., KAJITA, S., YAMAZAKI, R., HIGUCHI, S., KOZUKA, H. and NEMOTO, N., 1999, Comparison of 26,27-hexafluoro-1a,25-dihydroxyvitamin D3 and 1a,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo. Journal of Nutritional Science and Vitaminology, 45, 239–249.
  • MIYAMOTO, Y., SHINKI, T., YAMAMOTO, K., OHYAMA, Y., IWASAKI, H., HOSOTANI, R., KASAWA, T., TAKAYAMA, H., YAMADA, S. and SUDA, T., 1997, 1a-25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1, 25-dihydroxyvitamin D3. Journal of Biological Chemistry, 272, 14115–14119.
  • OHYAMA, Y., NOSHIRO, M. and OKUDA, K., 1991, Cloning and expressing of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase. FEBS Letters, 278, 195–198.
  • STERN, P. H., MARREAS, T., TANAKA, Y DELucA, H. F., IKEKAWA. N. and KoBAYASHI Y., 1984, Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1, 25-dihydroxyvitamin D on bone and intestine in vitro. Journal of Pharmacology and Experimental Therapeutics, 229, 9–13.
  • TANAKA, Y., DELuc A, H. F., KOBAYASHI, Y. and IKEKAWA, N., 1984, A highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. Archives of Biochemistry and Biophysics, 229, 348–354.
  • WATANABE, Y. and ISHIMURA, Y., 1989, Aromatization of tetralone derivatives by FeHIPFR(C1)/ PHIO and cytochrome P-450cam: a model study on aromatase P-450 reaction. Journal of the American Chemical Society, 111, 410–411.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.